Sanofi (SNY -0.3%) appears to be the last man standing to bid for for Bayer's (BAYRY.PK -0.9%)...

|About: Sanofi (SNY)|By:, SA News Editor

Sanofi (SNY -0.3%) appears to be the last man standing to bid for for Bayer's (BAYRY.PK -0.9%) blood glucose meter business, in a deal could be valued at $1.5B or more. The two companies are still off on the price however, and any agreement looks to be several weeks off - which means it's still possible another suitor could re-emerge. The market for glucose-control systems is growing, fueled by rising obesity and diabetes rates world-wide. It's estimated that the world-wide market for blood glucose self-monitoring devices will reach $12.2B in 2017, up from $8.9B in 2010 and $6.2B in 2003.